###begin article-title 0
Pathways to Injury in Chronic Pancreatitis: Decoding the Role of the High-Risk SPINK1 N34S Haplotype Using Meta-Analysis
###end article-title 0
###begin p 1
Conceived and designed the experiments: DW EA. Performed the experiments: EA CC. Analyzed the data: DW EA CC MB GP. Wrote the paper: DW EA JG.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 515 521 515 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 604 610 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
The complex interactions between recurrent trypsin-mediated pancreatic injury, alcohol-associated pancreatic injury and SPINK1 polymorphisms in chronic pancreatitis (CP) are undefined. We hypothesize that CP occurs as a result of multiple pathological mechanisms (pathways) that are initiated by different metabolic or environmental factors (etiologies) and may be influenced differentially by downstream genetic risk factors. We tested this hypothesis by evaluating the differences in effect size of the high risk SPINK1 N34S haplotype on CP from multiple etiologies after combining clinical reports of SPINK1 N34S frequency using meta-analysis.
###end p 3
###begin title 4
Methods and Findings
###end title 4
###begin p 5
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 254 260 254 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 539 545 539 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 831 832 831 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The Pubmed and the Embase databases were reviewed. We studied 24 reports of SPINK1 N34S in CP (2,421 cases, 4,857 controls) using reported etiological factors as surrogates for pathways and multiple meta-analyses to determine the differential effects of SPINK1 N34S between alcoholic and non-alcoholic etiologies. Using estimates of between-study heterogeneity, we sub-classified our 24 studies into four specific clusters. We found that SPINK1 N34S is strongly associated with CP overall (OR 11.00; 95% CI: 7.59-15.93), but the effect of SPINK1 N34S in alcoholic CP (OR 4.98, 95% CI: 3.16-7.85) was significantly smaller than in idiopathic CP (OR 14.97, 95% C.I. = 9.09-24.67) or tropical CP (OR 19.15, 95% C.I. = 8.83-41.56). Studies analyzing familial CP showed very high heterogeneity suggestive of a complex etiology with an I2 = 80.95%.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
The small effect of SPINK1 N34S in alcoholic subjects suggests that CP is driven through a different pathway that is largely trypsin-independent. The results also suggest that large effect sizes of SPINK1 N34S in small candidate gene studies in CP may be related to a mixture of multiple etiologic pathways leading to the same clinical endpoint.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 178 181 178 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Sarles1">[1]</xref>
###xml 277 280 277 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb1">[2]</xref>
###xml 368 374 <span type="species:ncbi:9606">humans</span>
Chronic pancreatitis (CP) is a common chronic inflammatory syndrome of the pancreas that has been defined by clinical signs and symptoms linked to end-stage pathological criteria[1]. While acute pancreatitis is recognized as an acute inflammatory response to pancreatic injury [2], the pathophysiological mechanisms underlying the development and progression of CP in humans have yet to be discerned.
###end p 9
###begin p 10
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Sarles1">[1]</xref>
###xml 142 145 142 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Etemad1">[3]</xref>
###xml 147 150 147 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Steer1">[4]</xref>
###xml 152 155 152 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Warshaw1">[5]</xref>
###xml 263 266 263 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Bachem1">[6]</xref>
###xml 268 271 268 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Omary1">[7]</xref>
###xml 563 566 563 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Sarles1">[1]</xref>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Etemad1">[3]</xref>
###xml 573 576 573 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Steer1">[4]</xref>
###xml 578 581 578 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Warshaw1">[5]</xref>
CP is defined by the presence of chronic inflammatory cells within the pancreas, progressive fibrosis, sclerosis and parenchymal atrophy [1], [3], [4], [5]. The pancreatic stellate cell (PSC) is the mediator of fibrosis, and is ubiquitous in chronic pancreatitis [6], [7]. The diagnosis of CP requires greater than six month duration of inflammation, permanent loss of exocrine function, and evidence on abdominal imaging studies of duct distortion, fibrosis or calcification. Abdominal pain and diabetes mellitus are clinical features that are also common to CP [1], [3], [4], [5].
###end p 10
###begin p 11
###xml 235 238 235 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Etemad1">[3]</xref>
###xml 240 243 240 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Lankisch1">[8]</xref>
###xml 554 557 554 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Lankisch1">[8]</xref>
###xml 559 562 559 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Yadav1">[9]</xref>
###xml 516 524 <span type="species:ncbi:9606">patients</span>
CP is sub-classified according to epidemiologic risk factors (e.g. alcoholism, family history, living in certain tropical regions, autoimmune disorders), although the relative risk of recognized environmental factors may be diminutive [3], [8]. If no inciting factor can be identified, CP is termed 'idiopathic' and sub-classified as early versus late-onset idiopathic CP by age of diagnosis. Although excessive alcohol consumption is a risk factor for CP, fewer than 5% of alcoholics develop pancreatitis, and many patients with CP do not drink alcohol [8], [9]. Furthermore, the pathophysiological pathways that link the normal pancreas to the end-stage pathology of CP have not been clearly defined.
###end p 11
###begin p 12
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRSS1</italic>
###xml 336 340 336 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb2">[10]</xref>
###xml 404 408 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Cohn1">[11]</xref>
###xml 416 420 416 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Sharer1">[12]</xref>
###xml 529 535 529 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 537 541 537 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Chen1">[13]</xref>
###xml 543 547 543 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Pfutzer1">[14]</xref>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Witt1">[15]</xref>
###xml 678 682 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Khalid1">[16]</xref>
###xml 684 688 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Lasson1">[17]</xref>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ogawa1">[18]</xref>
###xml 696 702 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 852 856 852 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb2">[10]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Witt1">[15]</xref>
###xml 15 20 <span type="species:ncbi:9606">human</span>
###xml 115 120 <span type="species:ncbi:9606">human</span>
Several recent human genetic studies have provided insight into components of the pathogenic mechanisms leading to human CP, all of which are related to failure to regulate intrapancreatic trypsin activity and the associated pancreatic injury. The three primary susceptibility genes for CP include the cationic trypsinogen gene (PRSS1) [10], the cystic fibrosis transmembrane conductance regulator gene (CFTR) [11], [12], and the pancreatic secretory trypsin inhibitor gene, also known as serine protease inhibitor Kazal type 1 (SPINK1) [13], [14], [15]. SPINK1 is an acute phase protein whose gene expression and protein concentrations are markedly upregulated by inflammation [16], [17], [18]. SPINK1 gene mutations are thought to diminish protection against prematurely activated trypsin, and are thereby linked to trypsin-related pancreatic injury [10], [15]. PRSS1, CFTR and SPINK1 seem to play complementary roles in protecting the pancreas from the damage incurred by prematurely activated trypsin.
###end p 12
###begin p 13
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Pfutzer1">[14]</xref>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb3">[19]</xref>
###xml 246 252 246 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Chen1">[13]</xref>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Witt1">[15]</xref>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis1">[20]</xref>
###xml 618 622 618 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis2">[21]</xref>
###xml 624 628 624 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Trikalinos1">[22]</xref>
###xml 678 684 678 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 1033 1041 1033 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g001">Figure 1</xref>
###xml 1184 1189 1184 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRSS1</italic>
###xml 1194 1198 1194 1198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 1556 1559 1556 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Yadav1">[9]</xref>
The high-risk SPINK1 N34S haplotype has been observed in one to three percent of most populations, while the incidence of CP is less than one in ten thousand [14], [19]. Furthermore, the reported range of odds ratios (ORs) describing the risk of SPINK1 N34S carriers of developing pancreatitis has varied from non-significance [13] to nearly 80 [15]. Wide variations in reported effects of small genetic association studies have been attributed to statistical variation in underpowered studies, poor methodology, publication bias toward studies with large ORs as well as a myriad of other non-biological factors [20], [21], [22]. However, we hypothesize that in the case of the SPINK1 N34S high-risk haplotype, the variation in reported effect sizes may be a result of differences in the proportion of subjects with pathogenic pathways linking environmental stressors to pancreatic stellate cell (PSC) activation through recurrent trypsinogen activation and inadequate trypsin inhibition by SPINK1. The basic model is illustrated in Figure 1. In this model, SPINK1-regulated pathways would include all upstream etiologic factors associated with recurrent trypsinogen activation (e.g. PRSS1 and CFTR mutations) while SPINK1-independent pathways would include factors that drive PSC to produce fibrosis through mechanisms that are generally independent of recurrent trypsinogen activation (e.g. autoimmune pancreatitis, toxins, pancreatic cancer). Although a number of functionally different risk factors have been statistically associated with alcoholic CP [9], it is not clear if the PSC and fibrosis in alcoholic CP is driven by trypsin-dependent, or independent pathways.
###end p 13
###begin title 14
Hypothesis of etiology-defined pathways to pancreatic fibrosis.
###end title 14
###begin p 15
###xml 182 183 182 183 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 186 187 186 187 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 190 191 190 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Hypothetical influence diagram illustrating pathologic pathways linking proximal factor (Factor A and B) to PSC (pancreatic stellate cell) and fibrosis through multiple steps (e.g. a1, a2, a3). Etiological factors of type B activate trypsinogen to trypsin, and therefore their pathologic pathway to the PSC can be interrupted by SPINK1. Etiological factors of type A are independent of trypsin, and therefore will not be influenced by variations in SPINK1 expression or function.
###end p 15
###begin p 16
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Lau1">[23]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis3">[24]</xref>
###xml 330 334 330 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb4">[25]</xref>
###xml 405 411 405 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 430 447 430 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pathway-dependent</italic>
###xml 561 567 561 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 746 752 746 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 928 934 928 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 104 109 <span type="species:ncbi:9606">human</span>
###xml 613 621 <span type="species:ncbi:9606">patients</span>
In order to address questions of heterogeneity, and specifically the role of alcohol and SPINK1 N34S in human CP, we employed meta-analysis in a manner illustrative of the growing realization that meta-analysis is most effective in examining relationships in complex diseases by evaluating between-study heterogeneity [23], [24], [25]. We tested the hypothesis that the true effect size of the functional SPINK1 N34S haplotype is pathway-dependent by reviewing the world literature and gathering data from case-control studies that evaluated the association of SPINK1 N34S with CP. When possible, we reclassified patients by reported etiology and performed a series of meta-analyses on each category to determine the effect size of the high-risk SPINK1 N34S haplotype within each etiologic sub-classification. We hypothesized that etiology-based categories defining a trypsin-dependent pathway would be associated with a larger SPINK1 N34S effect than those that were trypsin-independent.
###end p 16
###begin title 17
Methods
###end title 17
###begin p 18
###xml 53 59 53 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 236 243 236 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002003-t001">Table 1</xref>
We systematically reviewed the world's literature on SPINK1 polymorphisms. Only case-control studies were considered. When possible, subjects were classified according to reported etiology, with the following categories as presented in Table 1: Alcoholic chronic pancreatitis (ACP), idiopathic chronic pancreatitis (ICP), familial/hereditary chronic pancreatitis (FCP) and tropical pancreatitis (TP). We then conducted a series of meta-analyses combining subjects within etiology-based sub-classifications as described below.
###end p 18
###begin title 19
###xml 71 78 <span type="species:ncbi:9606">patient</span>
Case control studies considered for inclusion in the meta-analyses and patient subclassification within each study.
###end title 19
###begin p 20
Prevalence of the N34S polymorphism was not reported in the control population.
###end p 20
###begin p 21
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Schneider2">[55]</xref>
Data duplicated in Schneider et al [55].
###end p 21
###begin p 22
###xml 37 41 37 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Shimosegawa1">[65]</xref>
Data duplicated in Shimosegawa et al [65].
###end p 22
###begin p 23
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Kume1">[29]</xref>
Data duplicated in Kume et al[29].
###end p 23
###begin p 24
Dropped from the analysis because it did not identify the N34S polymorphism in either the cases or the controls therefore resulting in a null relative weight.
###end p 24
###begin p 25
###xml 22 30 <span type="species:ncbi:9606">patients</span>
Unable to subclassify patients into the mentioned categories due to missing data.
###end p 25
###begin p 26
PCR: Polymerase Chain Reaction, RFLP: Restricted Fragment Length Polymorphism, DGGE: Denaturing Gradient Gel Electrophoresis.
###end p 26
###begin title 27
Study selection criteria
###end title 27
###begin p 28
###xml 123 129 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 297 372 297 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">polymorphism(s), SPINK1, Serine Protease Inhibitor Kazal type 1, PSTI, N34S</italic>
###xml 377 389 377 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pancreatitis</italic>
###xml 608 614 608 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 643 651 <span type="species:ncbi:9606">patients</span>
The literature search and study review was performed by two separate authors (EA, DCW). Genetic association studies of the SPINK1 N34S high-risk haplotype in pancreatitis that were published prior to May 2007 were identified by searching the PubMed and the EMBASE databases. Search terms included polymorphism(s), SPINK1, Serine Protease Inhibitor Kazal type 1, PSTI, N34S and pancreatitis. The reference list of citations in the identified publications was reviewed to identify additional published articles not indexed by the major databases. Genetic association studies that reported the frequency of the SPINK1 N34S high-risk haplotype in patients with acute and/or chronic pancreatitis and in a control population were selected. When more than one published report used data from the same case and control population, we included only the largest study with extractable data in the meta-analysis. Corresponding authors were contacted in some cases to clarify issues of possible data duplication. Only studies that used validated genotyping methods, such as direct gene sequencing, polymerase chain reaction paired with restricted fragment length polymorphism and denaturing gradient gel electrophoresis, were included. Studies based on linkage results (pedigree studies), case reports, editorials, review articles and studies published in a language other than English were excluded.
###end p 28
###begin title 29
Data Abstraction
###end title 29
###begin p 30
###xml 552 560 <span type="species:ncbi:9606">patients</span>
Data abstraction was performed by two separate authors (EA, CC) and differences were resolved by discussion. The data elements included the first author, journal, year of publication, country of origin, racial background of the study population (when mentioned), demographics, reported etiology of CP (alcoholic, idiopathic, familial, tropical, etc) and the number of cases and controls. Allelic frequency, genotypic distribution and genotyping methods were recorded. All statistical analysis was based on the number of alleles-as opposed to number of patients, in order to better quantify homozygous cases.
###end p 30
###begin title 31
Statistical Methods
###end title 31
###begin p 32
###xml 58 64 58 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 304 310 304 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 485 486 485 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 602 603 602 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis4">[26]</xref>
###xml 667 671 667 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Higgins1">[27]</xref>
###xml 1095 1096 1095 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
For each study, we initially evaluated the association of SPINK1 N34S high-risk haplotype with CP separately. A preliminary meta-analysis combining all studies regardless of etiology was conducted. We then conducted a series of meta-analyses assessing the degree of risk of various categories of CP with SPINK1 N34S. Effect size was expressed as an OR with the corresponding 95% confidence interval (CI). Heterogeneity between studies was tested using the Cochran Q statistic and the I2 value. Because all statistical tests for heterogeneity are weak, we also included the 95% confidence interval for I2[26], which was calculated based on previously described methods[27]. When heterogeneity was not overtly evident, we performed the meta-analysis using both the fixed-effect (Mantel-Hanszel method) and the random-effect models (DerSimonian and Laird method). When heterogeneity was present, we only reported the results using the random-effect model. The Mantel-Hanszel (MH) method was selected over other fixed-effect methods because of potential small sample sizes of mutation carriers. An I2 value of 50 was considered the threshold, above which studies were considered too heterogeneous to be combined. The Haldane continuity correction (adding 0.5 to each cell) was used if the quantity of N34S-containing genotypes was equal to zero in either the cases or the controls. The presence of publication bias and small study effects were assessed using the Egger regression asymmetry test for funnel plot and the Begg-Mazumdar adjusted rank correlation test. Statistical significance was considered at a p-value of </=0.05. In cases where the polymorphism was not detected in either cases or controls, the study was omitted from the meta-analyses as it carried a relative weight of zero. All meta-analyses were conducted using Stata version 8.2 (Stata, Inc., College Station, Texas) and Comprehensive Meta-Analysis version 2.0 (Biostat Inc. Englewood, New Jersey).
###end p 32
###begin title 33
Results
###end title 33
###begin p 34
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g002">Figure 2</xref>
###xml 124 130 124 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 174 181 174 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002003-t001">Table 1</xref>
###xml 296 300 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Chen1">[13]</xref>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Keiles1">[28]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Kume1">[29]</xref>
###xml 402 406 402 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Rossi1">[30]</xref>
###xml 408 412 408 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Masamune1">[31]</xref>
###xml 459 463 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Bernardino1">[32]</xref>
Figure 2 is a flow diagram illustrating the studies included. Thirty case-control studies evaluating the association of the SPINK1 N34S polymorphism with CP were identified (Table 1). Two studies were excluded because the prevalence of the polymorphism was not reported in the control population [13], [28]. An additional three studies were excluded due to data duplication in other publications [29], [30], [31]. Additionally, The report by Bernardino et al [32] was excluded from the analysis because it did not identify the N34S polymorphism in either cases or controls. A total of 24 studies were therefore evaluated.
###end p 34
###begin title 35
Flow diagram of the studies included in the meta-analysis.
###end title 35
###begin p 36
* The report by Bernardino et al was excluded from the meta-analysis because it did not detect the N34S haplotype in neither the cases nor the controls and was therefore assigned a weight of zero.
###end p 36
###begin title 37
Chronic Pancreatitis-All etiologies combined
###end title 37
###begin p 38
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g003">Figure 3</xref>
###xml 341 342 341 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 218 225 <span type="species:ncbi:9606">patient</span>
Figure 3 summarizes the results of the initial meta-analysis with all etiologies of CP combined. The total number of patients from these studies was 2,421 with 4,857 controls. The mutation was detected in 469 of 4,842 patient alleles and in 96 of 9,714 control alleles. Significant heterogeneity was detected (Q = 41.05, df = 23, p = 0.01, I2 = 43.97%). The random effect model showed a combined OR of 11.00 (95% C.I. = 7.59-15.93). Both the Egger and the Begg-Mazumdar tests were not statistically significant with p = 0.65 and p = 0.94 respectively.
###end p 38
###begin title 39
Meta-analysis results for chronic pancreatitis all etiologies combined based on allelic frequency.
###end title 39
###begin p 40
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Heterogeneity testing: Q-value = 41.05, df = 23, p = 0.01, I2 = 43.97 (95% CI: 10.56-64.90).
###end p 40
###begin title 41
Alcoholic Chronic Pancreatitis
###end title 41
###begin p 42
###xml 307 313 307 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 354 360 354 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 532 533 532 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 694 702 694 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g004">Figure 4</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 414 421 <span type="species:ncbi:9606">patient</span>
###xml 754 762 <span type="species:ncbi:9606">patients</span>
We identified patients with alcoholic CP from 9 studies (737 patients, 2,033 controls). Overall, alcohol was the etiologic factor leading to chronic pancreatitis in 31% of the patients that we were able to classify. Six of nine studies failed to identify a statistically significant association between the SPINK1 N34S polymorphism and alcoholic CP. The SPINK1 N34S high-risk haplotype was reported in 49 of 1,474 patient alleles and in 37 of 4,066 control alleles. There was no heterogeneity detected (Q = 7.36, df = 8, p = 0.50, I2 = 0%). Both the fixed and the random-effect model showed a pooled OR of 4.98 (95% C.I. = 3.16-7.85)-the lowest among the different categories that we analyzed. Figure 4 summarizes the meta-analysis results pertaining to patients with alcoholic CP.
###end p 42
###begin title 43
Meta-analysis results for alcoholic chronic pancreatitis based on allelic frequency.
###end title 43
###begin p 44
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Heterogeneity testing: Q-value = 7.36, df = 8, p = 0.5, I2 = 0 (95% CI: 0.00-62.01).
###end p 44
###begin title 45
Tropical Chronic Pancreatitis
###end title 45
###begin p 46
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 355 363 355 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g005">Figure 5</xref>
###xml 22 30 <span type="species:ncbi:9606">patients</span>
###xml 63 71 <span type="species:ncbi:9606">patients</span>
###xml 139 146 <span type="species:ncbi:9606">patient</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
Four studies assessed patients with tropical pancreatitis (351 patients, 973 controls). The high-risk haplotype was detected in 168 of 702 patient alleles and in 44 of 1,946 control alleles. The heterogeneity testing showed Q = 5.72, df = 3, p = 0.13, I2 = 47.56%. The pooled OR calculated using the random-effect model was 19.15 (95% C.I. = 8.83-41.56). Figure 5 summarizes the meta-analysis results pertaining to patients with tropical pancreatitis.
###end p 46
###begin title 47
Meta-analysis results for tropical pancreatitis based on allelic frequency.
###end title 47
###begin p 48
###xml 58 59 58 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Heterogeneity testing: Q-value = 5.72, df = 3, p = 0.13, I2 = 47.56 (95% CI: 20.96-78.99).
###end p 48
###begin title 49
Idiopathic Chronic Pancreatitis
###end title 49
###begin p 50
###xml 158 164 158 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g006">figure 6</xref>
###xml 264 265 264 265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
Fourteen studies were included in this analysis (963 patients, 3,015 controls), only two of which did not detect a statistically significant association with SPINK1 N34S (figure 6). The Cochran's Q statistics was calculated at 20.86 with a p value of 0.08 and an I2 of 37.98%. The pooled OR was 14.97 (95% C.I. = 9.09-24.67).
###end p 50
###begin title 51
Meta-analysis results for idiopathic chronic pancreatitis based on allelic frequency.
###end title 51
###begin p 52
###xml 60 61 60 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Heterogeneity testing: Q-value = 20.86, df = 13, p = 0.08, I2 = 37.98 (95% CI: 0.00-65.00).
###end p 52
###begin title 53
Familial and Hereditary Chronic Pancreatitis
###end title 53
###begin p 54
###xml 17 25 <span type="species:ncbi:9606">patients</span>
Six studies (249 patients, 955 controls) were analyzed. Significant heterogeneity was detected by the Cochran Q statistic (Q = 26, df = 5, p = 0.00). Additionally, the I-squared value was 80.94%. Due to the high degree of heterogeneity, these studies were not combined.
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 237 241 237 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis3">[24]</xref>
###xml 533 539 533 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis1">[20]</xref>
###xml 719 723 719 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis2">[21]</xref>
###xml 836 844 836 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g003">Figure 3</xref>
###xml 973 979 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 1518 1526 1518 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g001">Figure 1</xref>
###xml 1312 1319 <span type="species:ncbi:9606">patient</span>
As stated in a recent article on meta-analysis: "It is well appreciated now that besides estimating summary effects, estimation and, if possible, explanation, of the between-study heterogeneity is a very important goal for meta-analysis"[24]. Furthermore, the article goes on to state that "in the presence of between-study heterogeneity in the genetic effects, there may be important implications for the interpretation of the results". The aim of the current study was to understand the associations between alcohol, the high-risk SPINK1 N34S haplotype, and CP, and to assess the strength of any association using etiology-based classifications from previously reported studies using meta-analyses. As expected [20], [21], we observed wide variation in ORs among small studies which was reflected in the global meta-analyses results (Figure 3). Stratifying subjects by commonly reported etiologies and performing subset meta-analysis to determine the specific effects of SPINK1 N34S in subpopulations, in some cases, revealed low variance. This finding suggests that these subpopulations are associated with more homogeneous pathological mechanisms. The different ORs and, occasionally, non-overlapping CIs (e.g. alcohol versus idiopathic, tropical etiologies) suggest that the CP syndrome encompasses several patient subpopulations, and may indicate that the pathologic pathway linking the proximal etiology to the PSCs in fibrosing CP are regulated to different degrees by the activity of SPINK1, as envisioned in Figure 1.
###end p 56
###begin p 57
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis1">[20]</xref>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Ioannidis2">[21]</xref>
When meta-analysis is applied to complex genetic syndromes, the measured effect size of a genetic variable between studies is often widely discrepant [20], [21]. A way to interpret the observation that very large effect sizes in small genetic studies are often not "reproducible" in subsequent studies has been attributed to a combination of false-positive findings (e.g. related to multiple testing without correction) and publication bias toward reports with large effect sizes.
###end p 57
###begin p 58
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb4">[25]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb5">[33]</xref>
Another potential explanation is that there are multiple sub-populations with different complex, multi-step etiologic pathways that all lead to the same phenotype (e.g. end-stage organ fibrosis). Thus, a genetic factor that is critical in one etiologic pathway will only be shown to have a large effect size in populations in which that pathways dominates [25], [33]. In other populations, in which the dominant etiological pathway is independent of the gene variant in question, the measured effect size of the genetic variant may be small.
###end p 58
###begin p 59
###xml 249 253 249 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Deng1">[34]</xref>
###xml 268 272 268 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Katz1">[35]</xref>
###xml 288 292 288 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb6">[36]</xref>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Apte1">[37]</xref>
###xml 328 334 328 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 579 586 579 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1-</italic>
###xml 632 640 632 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002003-g001">Figure 1</xref>
###xml 770 774 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Apte1">[37]</xref>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Fortunato1">[38]</xref>
###xml 782 786 782 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Wang1">[39]</xref>
Alcohol is a toxin that damages the pancreas by altering key regulatory processes, causing direct injury to acinar cells and driving stellate cells to produce fibrosis. Specifically, studies have shown that alcohol can act directly on the brainstem [34], acinar cells [35], immune system [36], and PSCs [37]. The association of SPINK1 N34S with the risk of alcoholic CP was significant, but the lowest of the subgroups. This observation suggests that while a portion of the insult may be associated with premature trypsinogen activation, alcohol's primary effects seem to be via SPINK1- independent pathways (similar to Factor A in Figure 1), and largely through the direct effects on the immune system and stellate cells, as has been demonstrated in animal experiments [37], [38], [39].
###end p 59
###begin p 60
###xml 128 134 128 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTSB</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Mahurkar1">[40]</xref>
###xml 558 562 558 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Halangk1">[41]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Szilagyi1">[42]</xref>
###xml 586 590 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CTSB</italic>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
The pathway leading from an unknown factor in tropical pancreatitis to PSC activation and fibrosis is more strongly affected by SPINK1 N34S then was seen in alcoholic CP. Although the proximal, presumably trypsin-associated factors are unknown, Mahurkar and colleagues have recently reported a higher incidence of mutations in the cathepsin B gene (CTSB) in patients with TP than controls [40]. Cathepsin B is a lysosomal enzyme present in pancreatic acinar cells that appears to be important in protecting the pancreas from premature trypsinogen activation [41], [42], suggesting that CTSB mutations may increase the risk of inappropriate trypsin activity within the acinar cells. This may be one of several critical factors contributing to the etiology of TP.
###end p 60
###begin p 61
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 278 284 278 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 339 343 339 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Noone1">[43]</xref>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PRSS1</italic>
###xml 489 493 489 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CFTR</italic>
###xml 528 534 528 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 895 899 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Witt1">[15]</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
###xml 758 766 <span type="species:ncbi:9606">children</span>
###xml 867 874 <span type="species:ncbi:4097">tobacco</span>
Patients with idiopathic CP had a significant association with the SPINK1 N34S polymorphism as evidenced by a pooled OR of 14.66. Noone et al. reported a high incidence of CFTR mutations in patients with ICP and further demonstrated that the combined risk of CFTR mutations and SPINK1 polymorphisms was multiplicative rather than additive [43]. Although the various etiologies of idiopathic CP are largely unknown, the significant enrichment of this group with subjects carrying PRSS1 and CFTR mutations and the large effect of SPINK1 polymorphisms with progression to CP is consistent with our proposed model. Of note, the highest reported OR of any study (OR = approximately80) was that of Witt et al that was conducted in a relatively homogenous group of children with early onset idiopathic CP where few, if any, environmental exposures played a role, especially tobacco smoking and alcohol [15]. Thus, the high OR reflected an enrichment of the pathway that is most strongly regulated by SPINK1 rather than the random effects of chance.
###end p 61
###begin p 62
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 292 296 292 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb2">[10]</xref>
###xml 700 706 700 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 810 816 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
The risk of familial and hereditary CP is strongly associated with SPINK1 N34S, but these data should be interpreted with caution. Hereditary pancreatitis is an autosomal dominant disorder with very high penetrance that is caused by gain-of-function mutation in the cationic trypsinogen gene [10]. The etiology of hereditary pancreatitis is unequivocally linked to trypsin-associated pathway of recurrent acute pancreatitis leading to CP, but the effect is to such a degree that normal expression of SPINK is not sufficient to prevent it. On the other hand, a major proportion of familial chronic pancreatitis that is not autosomal dominant is associated with multiple family members with homozygous SPINK1 mutations. In this case, the etiology-based classification system is biased toward an association with SPINK1. These factors likely contribute to the high heterogeneity of effects in this classification.
###end p 62
###begin p 63
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Schneider1">[44]</xref>
###xml 394 398 394 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002003-Whitcomb7">[45]</xref>
###xml 915 921 915 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 1054 1061 1054 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002003-t001">Table 1</xref>
###xml 88 93 <span type="species:ncbi:9606">human</span>
###xml 1350 1358 <span type="species:ncbi:9606">patients</span>
###xml 1577 1585 <span type="species:ncbi:9606">patients</span>
The current study has several limitations. One of the challenges in understanding CP in human subjects is distinguishing trypsin-dependent and trypsin-independent pathways in CP from the central role of trypsin in acute pancreatitis. Indeed, AP may be necessary to initiate CP by activating the immune system within the pancreas (including PSCs), thereby initiating the fibrosing process [44], [45]. Thus, although CP is driven by trypsin-depended and trypsin- independent factors, the fact that an individual is initially susceptible to the first episode of AP may blur the distinction between trypsin-dependent and trypsin-independent pathways to CP. Another limitation is that the published reports did not include or classify pancreatic fibrosis caused by autoimmune pancreatitis or pancreatic cancer, which, because they are thought to be trypsin-independent, would have been an important comparison group for SPINK1 N34S effects. Furthermore, the effect of ethnicity and race was usually not reported, although the country of origin was available (Table 1) and the etiologies of interest were clearly reported. Genetic polymorphisms often vary by race or ethnicity. Further studies are warranted to more thoroughly evaluate racial and/or ethnic variation in SPINK polymorphisms. Another limitation relies in the fact that classification of the patients into etiology-based subgroups was carried based on the etiologies listed in the manuscripts included in the analysis. It is unlikely that all twenty-four centers used the same criteria to diagnose and categorize these patients and therefore variations in the diagnostic criteria may explain some of the heterogeneity observed. Furthermore, a certain degree of misclassification may have occurred as a result and there is considerable residual heterogeneity beyond what the etiologic grouping can explain. Additionally, the presence of potential confounding variables or modifying factors could not be completely ruled out due to the limited amount of information and data assessing such factors in each study. Despite these challenges, clear differences in the effect of SPINK1 in different etiologies were observed.
###end p 63
###begin p 64
###xml 66 72 66 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 416 422 416 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
###xml 935 941 935 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SPINK1</italic>
In conclusion, meta-analysis of association studies examining the SPINK1 N34S polymorphism in CP confirms a significant overall pathologic association, although the reported effect size varies significantly depending on the etiology of CP. Modeling CP as a complex syndrome resulting from various pathogenic pathways with or without recurrent trypsinogen activation allows for the direct assessment of the effect of SPINK1 polymorphisms in the development of CP. While the subgroup analysis needs to be interpreted with caution, our results suggest that much of the variance in reported ORs between small studies of candidate genes in complex disorders may be attributed to a mixture of multiple etiologic pathways leading to a single clinical endpoint (e.g. organ fibrosis in CP). Alcohol appears to drive fibrosis in alcoholic CP primarily through a trypsin-independent pathway as reflected by the significantly lower association of SPINK1 N34S with this etiology. Additional studies are warranted to further assess the presence of any confounding or modifying factors and to elucidate the various pathophysiologic mechanisms involved and their implications in the etiology of CP.
###end p 64
###begin p 65
We thank Drs. Robert Ferrell, Nevin Oruc and Janette Lamb for helpful review and discussions.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
The pancreatitis classification of Marseilles-Rome 1988.
###end article-title 67
###begin article-title 68
Clinical practice. Acute pancreatitis.
###end article-title 68
###begin article-title 69
Chronic pancreatitis: diagnosis, classification, and new genetic developments.
###end article-title 69
###begin article-title 70
Chronic pancreatitis.
###end article-title 70
###begin article-title 71
AGA technical review: treatment of pain in chronic pancreatitis.
###end article-title 71
###begin article-title 72
Role of stellate cells in pancreatic fibrogenesis associated with acute and chronic pancreatitis.
###end article-title 72
###begin article-title 73
The pancreatic stellate cell: a star on the rise in pancreatic diseases.
###end article-title 73
###begin article-title 74
What is the risk of alcoholic pancreatitis in heavy drinkers?
###end article-title 74
###begin article-title 75
Alcohol-associated pancreatitis.
###end article-title 75
###begin article-title 76
Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene.
###end article-title 76
###begin article-title 77
Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.
###end article-title 77
###begin article-title 78
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Mutations of the cystic fibrosis gene in patients with chronic pancreatitis.
###end article-title 78
###begin article-title 79
###xml 27 32 <span type="species:ncbi:9606">human</span>
Mutational analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene in hereditary and sporadic chronic pancreatitis.
###end article-title 79
###begin article-title 80
SPINK1/PSTI polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis.
###end article-title 80
###begin article-title 81
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.
###end article-title 81
###begin article-title 82
###xml 14 17 <span type="species:ncbi:9606">man</span>
A 93 year old man with the PRSS1 R122H mutation, low SPINK1 expression, and no pancreatitis: insights into phenotypic non-penetrance.
###end article-title 82
###begin article-title 83
Elevated pancreatic secretory trypsin inhibitor levels during severe inflammatory disease, renal insufficiency, and after various surgical procedures.
###end article-title 83
###begin article-title 84
Pancreatic secretory trypsin inhibitor as an acute phase reactant.
###end article-title 84
###begin article-title 85
How to think about SPINK and pancreatitis.
###end article-title 85
###begin article-title 86
Replication validity of genetic association studies.
###end article-title 86
###begin article-title 87
Genetic associations in large versus small studies: an empirical assessment.
###end article-title 87
###begin article-title 88
Establishment of genetic associations for complex diseases is independent of early study findings.
###end article-title 88
###begin article-title 89
Summing up evidence: one answer is not always enough.
###end article-title 89
###begin article-title 90
Heterogeneity in meta-analyses of genome-wide association investigations.
###end article-title 90
###begin article-title 91
A systems biology approach to genetic studies of pancreatitis and other complex diseases.
###end article-title 91
###begin article-title 92
Uncertainty in heterogeneity estimates in meta-analyses.
###end article-title 92
###begin article-title 93
Quantifying heterogeneity in a meta-analysis.
###end article-title 93
###begin article-title 94
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
###end article-title 94
###begin article-title 95
###xml 82 90 <span type="species:ncbi:9606">patients</span>
Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis.
###end article-title 95
###begin article-title 96
SPINK1/PSTI mutations are associated with tropical pancreatitis in Bangladesh. A preliminary report.
###end article-title 96
###begin article-title 97
Differential roles of the SPINK1 gene mutations in alcoholic and nonalcoholic chronic pancreatitis.
###end article-title 97
###begin article-title 98
###xml 81 89 <span type="species:ncbi:9606">patients</span>
CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
###end article-title 98
###begin article-title 99
Evaluating disorders with a complex genetics basis. the future roles of meta-analysis and systems biology.
###end article-title 99
###begin article-title 100
Chronic alcohol-induced alterations in the pancreatic secretory control mechanisms.
###end article-title 100
###begin article-title 101
Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells.
###end article-title 101
###begin article-title 102
Value of genetic testing in the management of pancreatitis.
###end article-title 102
###begin article-title 103
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells.
###end article-title 103
###begin article-title 104
Pancreatic response to endotoxin after chronic alcohol exposure: switch from apoptosis to necrosis?
###end article-title 104
###begin article-title 105
Ethanol feeding alters death signaling in the pancreas.
###end article-title 105
###begin article-title 106
Association of cathepsin B gene polymorphisms with tropical calcific pancreatitis.
###end article-title 106
###begin article-title 107
Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis.
###end article-title 107
###begin article-title 108
###xml 55 60 <span type="species:ncbi:9606">human</span>
Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.
###end article-title 108
###begin article-title 109
Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations.
###end article-title 109
###begin article-title 110
Hereditary pancreatitis: a model for inflammatory diseases of the pancreas.
###end article-title 110
###begin article-title 111
Mechanisms of disease: Advances in understanding the mechanisms leading to chronic pancreatitis.
###end article-title 111
###begin article-title 112
High frequency of the N34S mutation in the SPINK1 gene in chronic pancreatitis detected by a new PCR-RFLP assay.
###end article-title 112
###begin article-title 113
Mutation in the SPINK1 trypsin inhibitor gene, alcohol use, and chronic pancreatitis.
###end article-title 113
###begin article-title 114
Mutations of the pancreatic secretory trypsin inhibitor (PSTI) gene in idiopathic chronic pancreatitis.
###end article-title 114
###begin article-title 115
###xml 16 21 <span type="species:ncbi:9606">human</span>
###xml 95 103 <span type="species:ncbi:9606">patients</span>
Analysis of the human pancreatic secretory trypsin inhibitor (PSTI) gene mutations in Japanese patients with chronic pancreatitis.
###end article-title 115
###begin article-title 116
The N34S mutation of SPINK1 (PSTI) is associated with a familial pattern of idiopathic chronic pancreatitis but does not cause the disease.
###end article-title 116
###begin article-title 117
Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis.
###end article-title 117
###begin article-title 118
Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
###end article-title 118
###begin article-title 119
Tropical calcific pancreatitis: strong association with SPINK1 trypsin inhibitor mutations.
###end article-title 119
###begin article-title 120
SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent.
###end article-title 120
###begin article-title 121
SPINK1/PSTI mutations are associated with tropical pancreatitis and type II diabetes mellitus in Bangladesh.
###end article-title 121
###begin article-title 122
Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
###end article-title 122
###begin article-title 123
###xml 66 74 <span type="species:ncbi:9606">patients</span>
Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis.
###end article-title 123
###begin article-title 124
Limited contribution of the SPINK1 N34S mutation to the risk and severity of alcoholic chronic pancreatitis: a report from the United States.
###end article-title 124
###begin article-title 125
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Mutations in the SPINK1 gene in idiopathic pancreatitis Italian patients.
###end article-title 125
###begin article-title 126
###xml 194 202 <span type="species:ncbi:9606">patients</span>
Mutation analysis of the cystic fibrosis transmembrane conductance regulator (CFTR) gene, the cationic trypsinogen (PRSS1) gene, and the serine protease inhibitor, Kazal type 1 (SPINK1) gene in patients with alcoholic chronic pancreatitis.
###end article-title 126
###begin article-title 127
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer.
###end article-title 127
###begin article-title 128
Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
###end article-title 128
###begin article-title 129
###xml 46 54 <span type="species:ncbi:9606">patients</span>
Mutations N34S and P55S of the SPINK1 gene in patients with chronic pancreatitis or pancreatic cancer and in healthy subjects: a report from Finland.
###end article-title 129
###begin article-title 130
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Mutation analysis of SPINK1 and CFTR gene in Korean patients with alcoholic chronic pancreatitis.
###end article-title 130
###begin article-title 131
SPINK1 gene mutations and pancreatitis in Japan.
###end article-title 131
###begin article-title 132
###xml 53 61 <span type="species:ncbi:9606">children</span>
Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
###end article-title 132
###begin article-title 133
Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis.
###end article-title 133
###begin p 134
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 134
###begin p 135
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by NIH R01 DK61451 (DCW) and T32-DK063922 (JBG).
###end p 135

